Garner Health Closes $100M to Scale AI Platform

The big picture: Garner Health has closed a $100 million Series E funding round at a $2.74 billion valuation. The company operates a digital platform that combines detailed provider data with financial incentives to help patients find high-performing doctors.

Why it matters:

• Rising costs: U.S. employer healthcare costs are projected to increase significantly, with Aon forecasting a 9.5 percent rise in 2026, pushing per-employee costs above $17,000.
• Poor doctor selection: Most patients choose doctors based on unreliable factors like location or friend referrals, missing crucial information about actual outcomes and complication rates.
• Misaligned incentives: Standard insurance plans offer no financial incentive for patients to seek out higher-quality, more efficient healthcare providers, perpetuating suboptimal choices.

How it works:

• Data-driven scoring: Garner’s platform scores physicians using a claims database of over 60 billion medical records, generating more than 550 clinical metrics to rank providers on quality and efficiency.
• Financial incentives: Employers cover most or all out-of-pocket costs when members choose a top-ranked doctor, leading to an average 80 percent reduction in out-of-pocket costs for members and a reported 12 percent reduction in total employer healthcare spending.
• AI-powered tools: The Garner Research Agent continuously updates clinical scoring algorithms using medical literature, while the Garner Assistant helps members find in-network doctors, book appointments, and manage benefits.

The catch: The healthcare market is highly fragmented and resistant to change, making widespread adoption of new platforms challenging despite clear benefits. While Garner’s approach addresses a critical need, it operates in a competitive landscape with numerous health tech solutions vying for employer attention, from traditional insurers to other digital health platforms. The effectiveness of financial incentives in consistently altering deeply ingrained patient behaviors around doctor selection remains a long-term test.